Close Menu

NEW YORK (GenomeWeb) – Metabolon announced today that it has partnered with Israeli precision medicine firm InnVentis to study metabolomics in individuals with chronic inflammatory diseases such as rheumatoid arthritis.

The deal joins Metabolon's metabolomics expertise with InnVentis' big data and machine learning platform, the company said. Specific terms of the partnership were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.